Did you miss one of our webinars? Simply select the appropriate link below and view the recorded webinar. It will not be interactive, but you will see the chat questions the original attendees asked. For additional information on the products discussed in the webinar, explore our links to videos and other resources.
If there is an area you would like to see covered, you can
request a topic of your choice.
If you are experiencing issues opening the webinar recordings, please be sure that you have the latest
Adobe Flash Player installed.
Please select a webinar type
Molecular Diagnostics (MDx)
Wednesday, November 28, 2018
Dr. Terry Riss and Andrew Niles, Promega Corporation
Which cell health assay should I choose? How do cell viability, cytotoxicity or apoptosis assays work? How can I monitor cell health in real-time? If you’re new to cell health or have questions about your current assay, join us for this Q&A session. Our cell health experts will help you get the answers you need!
Wednesday, November 14, 2018
Dr. Peter de Knijff
Forensic laboratories have much to consider before adopting massively parallel sequencing (MPS). In this webinar, Dr. Peter de Knijff will discuss considerations around implementation of MPS in the forensic laboratory, including advantages and disadvantages, workflow and data analysis, and results from his work using a prototype of the PowerSeq™ 46GY System.
Tuesday, November 13, 2018
Kristin M. Riching
Despite the promising potential of PROTAC compounds in new drug discovery strategies, interrogating the multiple steps required to achieve effective PROTAC-mediated target protein degradation remains a challenge. This webinar will describe a platform of live-cell assays that can be used to measure real-time degradation kinetics and key cellular protein interactions mediating the degradation process. Join us to learn how these tools can be used to improve functional and cellular characterization of your PROTAC compounds.
Tuesday, November 06, 2018
Matthew Robers and Kelvin Lam
Methods for measuring kinase inhibitor potency in live cells are limited. In this webinar, we describe how the NanoBRET™ Target Engagement technique is overcoming technical limitations of existing methods by broadly enabling quantitative determination of kinase inhibitor occupancy in live cells. We also discuss a collaboration between Promega and Reaction Biology Corporation that has enabled conversion of these assays into a service compatible with high-throughput cell-based profiling.
Tuesday, October 23, 2018
Dan Lazar, PhD and Gary Allenby, PhD
Monitoring autophagy using imaging or western blotting methods can be cumbersome, low-throughput and subjective. Learn about a new LC3 reporter assay with three modalities (plate-reader based, imaging and blotting) to help scale up your autophagy analysis with confidence.